Mirum Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $646.6M
Liabilities Breakdown FY2023
Total Liabilities: $398.0M
Asset Breakdown
Total Assets: $646.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $286.3M | 44.3% |
| Accounts Receivable | $68.0M | 10.5% |
| Inventory | $22.3M | 3.5% |
| Property, Plant & Equipment | $706.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $252.9M | 39.1% |
| Other Assets | $16.4M | 2.5% |
Liabilities Breakdown
Total Liabilities: $398.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.4M | 1.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $390.5M | 98.1% |